HK1060883A1 - Chemical compounds. - Google Patents

Chemical compounds.

Info

Publication number
HK1060883A1
HK1060883A1 HK04103858A HK04103858A HK1060883A1 HK 1060883 A1 HK1060883 A1 HK 1060883A1 HK 04103858 A HK04103858 A HK 04103858A HK 04103858 A HK04103858 A HK 04103858A HK 1060883 A1 HK1060883 A1 HK 1060883A1
Authority
HK
Hong Kong
Prior art keywords
chemical compounds
formula
compounds
present
beta
Prior art date
Application number
HK04103858A
Other languages
English (en)
Inventor
David N Deaton
Barry George Shearer
David Edward Uehling
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1060883A1 publication Critical patent/HK1060883A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK04103858A 2001-01-31 2004-05-28 Chemical compounds. HK1060883A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0102408.2A GB0102408D0 (en) 2001-01-31 2001-01-31 Chemical compounds
PCT/US2001/049299 WO2002060885A1 (en) 2001-01-31 2001-12-17 Chemical compounds

Publications (1)

Publication Number Publication Date
HK1060883A1 true HK1060883A1 (en) 2004-08-27

Family

ID=9907834

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103858A HK1060883A1 (en) 2001-01-31 2004-05-28 Chemical compounds.

Country Status (23)

Country Link
EP (1) EP1366033B1 (no)
JP (1) JP2004521895A (no)
KR (1) KR20030070923A (no)
CN (1) CN1487928A (no)
AT (1) ATE294167T1 (no)
AU (1) AU2002246720B2 (no)
BR (1) BR0116854A (no)
CA (1) CA2434853A1 (no)
CZ (1) CZ20032085A3 (no)
DE (1) DE60110468T2 (no)
DK (1) DK1366033T3 (no)
ES (1) ES2240557T3 (no)
GB (1) GB0102408D0 (no)
HK (1) HK1060883A1 (no)
HU (1) HUP0303026A3 (no)
IL (2) IL156639A0 (no)
MX (1) MXPA03006847A (no)
NO (1) NO20033401L (no)
NZ (1) NZ526846A (no)
PL (1) PL363359A1 (no)
PT (1) PT1366033E (no)
WO (1) WO2002060885A1 (no)
ZA (1) ZA200305770B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207964D0 (en) * 1992-04-10 1992-05-27 Ici Plc Chemical compounds
AU2737295A (en) * 1994-06-09 1996-01-04 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
NO20033401D0 (no) 2003-07-30
BR0116854A (pt) 2004-02-25
KR20030070923A (ko) 2003-09-02
NZ526846A (en) 2004-10-29
ZA200305770B (en) 2004-10-25
GB0102408D0 (en) 2001-03-14
ES2240557T3 (es) 2005-10-16
EP1366033A1 (en) 2003-12-03
CZ20032085A3 (cs) 2003-12-17
HUP0303026A2 (hu) 2003-12-29
WO2002060885A1 (en) 2002-08-08
IL156639A0 (en) 2004-01-04
MXPA03006847A (es) 2003-11-13
PL363359A1 (en) 2004-11-15
AU2002246720B2 (en) 2004-07-22
ATE294167T1 (de) 2005-05-15
CA2434853A1 (en) 2002-08-08
PT1366033E (pt) 2005-08-31
CN1487928A (zh) 2004-04-07
DK1366033T3 (da) 2005-08-15
JP2004521895A (ja) 2004-07-22
NO20033401L (no) 2003-09-30
DE60110468T2 (de) 2006-02-23
DE60110468D1 (de) 2005-06-02
IL156639A (en) 2006-12-31
EP1366033B1 (en) 2005-04-27
HUP0303026A3 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
RS20060320A (en) Substituted indazole-o-glucosides
SG130189A1 (en) Substituted indole-o-glucosides
HK1068335A1 (en) Novel arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
UA87991C2 (en) Substituted indole-o-glucosides
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
IL165257A0 (en) 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obestity anddyslipidemia
TW200608961A (en) Methods and reagents for the treatment of metabolic disorders
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
AU2002358390A1 (en) Novel compounds
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
NL1021504A1 (nl) Waterstofbehandelingsproces.
WO2005039626A3 (en) Use of hydroxylated amino acids for treating diabetes
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
HK1060883A1 (en) Chemical compounds.
AU2002231777A1 (en) Use of mglur5 antagonists for the treatment of pruritic conditions
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
EP1436279A4 (en) CHEMICAL COMPOUNDS
SE0202608D0 (sv) New sequences
SG153858A1 (en) Regulators of bacterial signalling pathways
ZA200308097B (en) Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091217